Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.14
Delayed Data
As of Feb 12
 +0.19 / +3.19%
Today’s Change
3.71
Today|||52-Week Range
10.74
-28.19%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Regals Capital Management Lp
Sale12/23/2015290,459$3.77$1.1M-31.09%
Kidron Miriam
Chief Technology Officer
Sale12/30/201524,000$8.61$206.6K-29.18%
Kidron Miriam
Chief Technology Officer
Sale12/29/201515,000$9.08$136.2K-31.32%
Kidron Miriam
Chief Technology Officer
Sale12/28/201511,000$9.27$102.0K-33.19%
Berelowitz Michael
Director
Sale12/08/2015761$8.70$6.6K-34.96%
Berelowitz Michael
Director
Sale12/09/2015700$9.44$6.6K-34.33%
Berelowitz Michael
Director
Sale12/07/2015539$8.70$4.7K-26.90%
Kidron Nadav
President & Chief Executive Officer
Buy3/19/20151,100$3.92$4.3K+54.27%
Kidron Nadav
President & Chief Executive Officer
Buy3/18/2015500$3.80$1.9K+64.61%
Kidron Nadav
President & Chief Executive Officer
Buy3/18/2015500$3.78$1.9K+64.61%
Page of 3